Farallon Capital Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$77.8M Sell
368,000
-208,000
-36% -$44.8M 0.44% 36
2025
Q4
$118M Buy
576,000
+323,000
+128% +$60.8M 0.54% 43
2025
Q3
$39.7M Sell
253,000
-201,000
-44% -$31M 0.16% 61
2025
Q2
$76.3M Buy
454,000
+181,000
+66% +$26.9M 0.32% 49
2025
Q1
$37.6M Buy
+273,000
New +$34.8M 0.18% 62

Other funds holding CAH

Farallon Capital Management's CAH Position: Q1 2026 in Review

Farallon Capital Management reduced its Cardinal Health (CAH) stake by 36% in Q1 2026, selling an estimated $44.8M and leaving 368,000 shares worth $77.8M. The position accounts for 0.44% of the portfolio, ranked #36.

Farallon Capital Management first reported a position in CAH in Q1 2025 and has held it in 5 quarters since. The position peaked at $118M in Q4 2025. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • Farallon Capital Management held 368,000 shares of Cardinal Health worth $77.8M as of Q1 2026.
  • Farallon Capital Management sold 208,000 Cardinal Health shares in Q1 2026, an estimated $44.8M.
  • Cardinal Health made up 0.44% of Farallon Capital Management's portfolio in Q1 2026, its #36 holding.
  • Farallon Capital Management first reported a position in Cardinal Health in Q1 2025 and has held it in 5 quarters since.
  • Farallon Capital Management's Cardinal Health position peaked at $118M in Q4 2025.
  • 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Farallon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.